Literature DB >> 29925004

Full Functional Knockout of Placental Growth Factor by Knockin with an Inactive Variant Able to Heterodimerize with VEGF-A.

Ivana Apicella1, Valeria Cicatiello1, Dario Acampora1, Valeria Tarallo1, Sandro De Falco2.   

Abstract

Placental growth factor (PlGF) is a proangiogenic member of the vascular endothelial growth factor (VEGF) family playing a central role in pathological angiogenesis. PlGF-DE is a PlGF variant unable to bind vascular endothelial growth factor receptor 1 (VEGFR-1) but still able to generate heterodimer with VEGF-A. We have generated PlGF-DE knockin mice that are vital and fertile and show unaltered expression of Plgf, Vegf-a, Vegfr-1, and Vegfr-2 compared with wild-type mice. Interestingly, these mutants showed additional and remarkable angiogenesis impairment in tumor growth, hindlimb ischemia, and choroidal neovascularization compared with both PlGF knockout and wild-type mice. These findings provided insights on VEGF-A/PlGF heterodimer function, which was able to rescue neovascularization and vascular leakage in PlGF-DE knockin mice. Collectively, these data show that PlGF-DE knockin mouse could be considered the full functional knockout of PlGF, suggesting a reassessment of the phenotypes of knockout mice for the genes whose products are able to generate heterodimeric proteins.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PlGF; VEGF/PlGF heterodimer; angiogenesis; mouse model; pathological neovascularization

Year:  2018        PMID: 29925004     DOI: 10.1016/j.celrep.2018.05.067

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  4 in total

1.  Synergistic interactions of PlGF and VEGF contribute to blood-retinal barrier breakdown through canonical NFκB activation.

Authors:  Anton Lennikov; Anthony Mukwaya; Lijuan Fan; Madhu Sudhana Saddala; Sandro De Falco; Hu Huang
Journal:  Exp Cell Res       Date:  2020-10-29       Impact factor: 3.905

2.  Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization.

Authors:  Valeria Tarallo; Emanuela Iaccarino; Valeria Cicatiello; Riccardo Sanna; Menotti Ruvo; Sandro De Falco
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

Review 3.  Mineralocorticoid Receptor Activation in Vascular Insulin Resistance and Dysfunction.

Authors:  Aderonke E Igbekele; George Jia; Michael A Hill; James R Sowers; Guanghong Jia
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208

Review 4.  VEGFR1 signaling in retinal angiogenesis and microinflammation.

Authors:  Akiyoshi Uemura; Marcus Fruttiger; Patricia A D'Amore; Sandro De Falco; Antonia M Joussen; Florian Sennlaub; Lynne R Brunck; Kristian T Johnson; George N Lambrou; Kay D Rittenhouse; Thomas Langmann
Journal:  Prog Retin Eye Res       Date:  2021-02-25       Impact factor: 21.198

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.